Section 9
Chapter 8,545

Effect of recombinant human interleukin-6 (rhIL-6) and rhIL-3 on hematopoietic regeneration as demonstrated in a nonhuman primate chemotherapy model

Winton, E.F.; Srinivasiah, J.; Kim, B.K.; Hillyer, C.D.; Strobert, E.A.; Orkin, J.L.; Swenson, R.B.; McClure, H.M.; Myers, L.A.; Saral, R.

Blood 84(1): 65-73


ISSN/ISBN: 0006-4971
PMID: 8018931
DOI: 10.1182/blood.v84.1.65.65
Accession: 008544404

Download citation:  

Using a recently developed hepsulfam-induced pancytopenia model in rhesus macaques, we have studied the effects of recombinant human interleukin-6 (rhIL-6) and rhIL-3 on marrow regeneration. Control animals were given hepsulfam (1.5 g/m-2 by a single 30-minute intravenous (IV) injection, n = 4), while study animals received hepsulfam followed by rhIL-6, rhIL-3, or a combination of rhIL-6 and rhIL-3 (n = 3 per study group).

PDF emailed within 0-6 h: $19.90